Orikami Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 2

Orikami General Information

Description

Developer of medical-grade digital biomarker technology designed to make an impact in chronic disease areas. The company's technology uses an artificial intelligence-powered digital biomarker platform and speeds up the journey from biomarker discovery through validation to delivery at scale, enabling medical specialists to make decision support, treatment support, and patient coaching.

Contact Information

Website
www.orikami.nl
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ridderstraat 29
  • 6511 TM Nijmegen
  • Netherlands
+31 024
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Vertical(s)
SaaS, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • Ridderstraat 29
  • 6511 TM Nijmegen
  • Netherlands
+31 024

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orikami Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 03-Jun-2022 Completed Generating Revenue
3. Seed Round 31-May-2021 Completed Generating Revenue
2. Debt - General 16-Jul-2020 $661K Completed Generating Revenue
1. Seed Round 02-Oct-2019 $661K $661K Completed Generating Revenue
To view Orikami’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Orikami Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orikami Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
CbusineZ Corporate Venture Capital Minority
Healthy.Capital Venture Capital Minority
To view Orikami’s complete investors history, request access »

Ready to get started?

Request a free trial

Orikami FAQs

  • When was Orikami founded?

    Orikami was founded in 2011.

  • Where is Orikami headquartered?

    Orikami is headquartered in Nijmegen, Netherlands.

  • What is the size of Orikami?

    Orikami has 15 total employees.

  • What industry is Orikami in?

    Orikami’s primary industry is Other Healthcare Technology Systems.

  • Is Orikami a private or public company?

    Orikami is a Private company.

  • What is Orikami’s current revenue?

    The current revenue for Orikami is .

  • How much funding has Orikami raised over time?

    Orikami has raised $661K.

  • Who are Orikami’s investors?

    CbusineZ and Healthy.Capital have invested in Orikami.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process